Sperzel John J III

Chairman and CEO at T2 Biosystems, Inc.

Sold, on record
$6k
Dollars the filings state
Form 4 sales
1
Latest Feb 28, 2023
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale T2 Biosystems, Inc.Unusual
    Feb 28, 2023 2023

    Sold 9,773 shares at $0.63 ($6k)

    Sperzel John J III, Chairman and CEO

    Sold 36.1% of holdings ($17k position)17,329 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Sperzel John J III
Source
Feb 28, 2023Mar 9, 2023T2 Biosystems, Inc.Chairman and CEOForm 4 sale9,773$6k36.1%UnusualSEC